Target Details
| UniProt AC | P43405 |
|---|---|
| Gene Symbol | SYK |
| Protein Name | Tyrosine-protein kinase SYK |
| Organism | Homo sapiens |
| Entry Name | |
| Organism Category | Human |
| Pfam Domains | PF07714 (PK_Tyr_Ser-Thr) PF00017 (SH2) |
Summary
- Multi-target molecules 852
- Clinical molecules 32
- Avg pChEMBL 7.25
KEGG Pathways (17)
- B cell receptor signaling pathway
- C-type lectin receptor signaling pathway
- Coronavirus disease - COVID-19
- Epstein-Barr virus infection
- Fc epsilon RI signaling pathway
- Fc gamma R-mediated phagocytosis
- Herpes simplex virus 1 infection
- Kaposi sarcoma-associated herpesvirus infection
- NF-kappa B signaling pathway
- Natural killer cell mediated cytotoxicity
- Neutrophil extracellular trap formation
- Osteoclast differentiation
- PI3K-Akt signaling pathway
- Phospholipase D signaling pathway
- Platelet activation
- Tuberculosis
- Viral carcinogenesis
Associated Diseases (1)
Active Molecules (852)
| InChIKey | pChEMBL | Type | Targets | Clinical | |
|---|---|---|---|---|---|
KRAOZXBAPOLPAO
|
8.5 | IC50 | 4 | — | |
NKJNHXKAASJVEM
|
8.5 | IC50 | 3 | — | |
QJIXTISVQSBZTF
|
8.5 | IC50 | 3 | — | |
USUSRWRXNKNUGL
|
8.5 | IC50 | 3 | — | |
XIFFATZVUNRCKL
|
8.5 | IC50 | 2 | — | |
ZGECDOGOLBHKSC
|
8.5 | IC50 | 3 | — | |
HKSZLNNOFSGOKW
|
8.5 | Ki | 118 | — | |
MVJMMLFMPWITEJ
|
8.5 | Ki | 110 | — | |
MJHOMTRKVMKCNE
|
8.5 | IC50 | 12 | — | |
BPJALVMFXXJAJS
|
8.4 | IC50 | 3 | — | |
DNSZJAFGHJNCIE
|
8.4 | IC50 | 3 | — | |
DQLUUNQMRQJPAL
|
8.4 | IC50 | 3 | — | |
HAUBKMWJXJVTIJ
|
8.4 | IC50 | 3 | — | |
JCSZOMMQIMMAMS
|
8.4 | IC50 | 4 | — | |
JFWWGRGDYNSADT
|
8.4 | IC50 | 2 | — | |
LKLIRPMEYRVLFV
|
8.4 | IC50 | 3 | — | |
POOFOKSCEYCHJC
|
8.4 | IC50 | 3 | — | |
RVIMFNLCTIXVKN
|
8.4 | IC50 | 4 | — | |
XTWSYOAQXZVJEI
|
8.4 | IC50 | 3 | — | |
ZFAJIINWCGZNAM
|
8.4 | IC50 | 3 | — | |
FVSUKLKFSDSIEF
|
8.4 | IC50 | 4 | — | |
NZNTWOVDIXCHHS
|
8.3 | IC50 | 4 | — | |
YLCFOHVAOBLAIK
|
8.3 | IC50 | 14 | — | |
BSGXDJPCRLBTKU
|
8.3 | IC50 | 3 | — | |
DTYGFXKVLYKJLW
|
8.3 | IC50 | 3 | — | |
GISQWMVPDCAGDF
|
8.3 | IC50 | 3 | — | |
JNMZHJBQPQFBDM
|
8.3 | IC50 | 3 | — | |
LTNUJJDDRIVIPZ
|
8.3 | IC50 | 2 | — | |
QFXFIEVXAUEHEV
|
8.3 | IC50 | 6 | — | |
VARYUMXVRFFXLR
|
8.3 | IC50 | 3 | — | |
VXMFHVFTECVHPF
|
8.3 | IC50 | 4 | — | |
XGOUHJLISKQBDN
|
8.3 | IC50 | 4 | — | |
YNNNBSQQVGIBKM
|
8.3 | IC50 | 2 | — | |
ZIINFLBIDWJGEF
|
8.3 | IC50 | 3 | — | |
MICOMLRETSSUOK
|
8.2 | IC50 | 3 | — | |
DVAXQAPODFQWRX
|
8.2 | IC50 | 2 | — | |
IICSZMDQEOSVKN
|
8.2 | IC50 | 3 | — | |
OGQDHXGPFCDXGA
|
8.2 | IC50 | 4 | — | |
XAZBDQHARDGYFI
|
8.2 | IC50 | 2 | — | |
YGAUGCRQWVWVJK
|
8.2 | IC50 | 4 | — | |
DPEXRCOBPACFOO
|
8.2 | Ki | 36 | — | |
CCRFXSGDDYALRL
|
8.2 | IC50 | 3 | — | |
DEYILQIXALFSOO
|
8.2 | IC50 | 3 | — | |
GOMLJGVTZFYKJG
|
8.2 | IC50 | 3 | — | |
GYAOYHATHSUFRX
|
8.2 | IC50 | 3 | — | |
IENMCFUQXWPNTA
|
8.2 | IC50 | 2 | — | |
LZQQEGBCKOIYIP
|
8.2 | IC50 | 4 | — | |
OCGMYHIDTHTZSV
|
8.2 | IC50 | 4 | — | |
QGDUHRXRHUCXIQ
|
8.2 | IC50 | 3 | — | |
QGEZMNVGCVUCMW
|
8.2 | IC50 | 2 | — |